Details for New Drug Application (NDA): 014764
✉ Email this page to a colleague
NDA 014764 describes ROBINUL, which is a drug marketed by Hikma, Robins Ah, and Casper Pharma Llc, and is included in three NDAs. It is available from four suppliers. Additional details are available on the ROBINUL profile page.
The generic ingredient in ROBINUL is glycopyrrolate. There are seventeen drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.
The generic ingredient in ROBINUL is glycopyrrolate. There are seventeen drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.
Summary for 014764
| Tradename: | ROBINUL |
| Applicant: | Robins Ah |
| Ingredient: | glycopyrrolate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 014764
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.2MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
